FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Source/Disclosures Published by: Disclosures: Biden and Walensky report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email
Read MoreBristol Myers Squibb on Friday sued the Biden administration over Medicare’s new powers to negotiate drug prices, the third such
Read MoreA Tennessee doctor has lost his medical license for issuing covid-19 vaccine waivers to patients he never met in at
Read MoreSource/Disclosures Disclosures: Healio was unable to determine relevant financial disclosures at the time of publication. ADD TOPIC TO EMAIL ALERTS
Read MoreIn fall 2021, staffers at Johnson Memorial Health were hoping they could finally catch their breath. They were just coming
Read MoreAs hot days become more extreme and common, California education researchers are urging that school districts be required to develop
Read MoreCompanies that made, sold, or distributed opioid painkillers are paying out more than $50 billion in settlements over nearly two
Read MoreThousands of local governments nationwide are receiving settlement money from companies that made, sold, or distributed opioid painkillers, like Johnson
Read MoreSource/Disclosures sources: Ross PA, et al. Association between race and obesity and outcomes for critical asthma in children. Presented at:
Read MoreA woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination center in Antwerp, Belgium,
Read More